CA AB1520

Prohibits health care service plans and health insurance policies issued, amended, or renewed on or after January 1, 2022, from applying deductibles, copayments, or coinsurance to prostate cancer screening services for enrollees and insureds who are 55 years of age or older.

Extends the same cost-sharing prohibition to individuals 40 years of age or older who are determined by their health care provider to be high risk, including those who are Black, have a family history of prostate cancer, have a genetic predisposition to prostate cancer, or are veterans.

Maintains existing law requiring coverage for prostate cancer screening and diagnosis services, including prostate-specific antigen testing and digital rectal examinations when medically necessary.

Exempts specified accident, specified disease, hospital indemnity, Medicare supplement, and long-term care health insurance policies from these requirements.

Specifies that for high deductible plans, the cost-sharing prohibition is subject to federal preventive care safe harbor guidance under 26 U.S.C. Sec. 223(c)(2)(C).